Verastem

More data, more dollars: Three biotechs post offerings after trial readouts
Endpoints
Wed, 01/25/23 - 11:00 pm
clinical trials
Jasper Therapeutics
Verastem
Precigen
Verastem takes on debt to get RAS tumor program to finish line
Fierce Biotech
Mon, 03/28/22 - 10:10 am
Verastem
ovarian cancer
non-small cell lung cancer
funding
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
The duvelisib hot potato is tossed to a new owner as Verastem looks to reorganize around the pipeline
Endpoints
Mon, 08/10/20 - 10:59 pm
duvelisib
Verastem
AbbVie
Verastem Oncology announces preliminary data from investigator-initiated study highlighting clinical activity of RAF/MEK and FAK combination in KRAS mutant tumors
Pharmaceutical Business Review
Mon, 04/27/20 - 09:34 am
Verastem
clinical trials
VS-6766
solid tumors
AACR
Verastem Oncology Sees Strategic Realignment To Reduce Its Operating Expenses By About 40% For 2020
Reuters
Fri, 02/28/20 - 10:46 am
Verastem
realignment
layoffs
Verastem pens KRAS-focused drug licensing deal with Chugai
Fierce Biotech
Wed, 01/8/20 - 10:34 am
Verastem
KRAS
cancer
Chugai
Forrester steps down as CEO of Verastem
Fierce Biotech
Thu, 06/20/19 - 10:10 am
Verastem
Robert Forrester
Pharma CEOs
Unwanted by AbbVie and Infinity, battered Verastem gets an OK for duvelisib and a second shot at success
Endpoints
Mon, 09/24/18 - 08:26 pm
Verastem
AbbVie
Infinity Pharmaceuticals
duvelisib
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
Xconomy
Fri, 02/9/18 - 09:34 am
Verastem
Infinity Pharma
FDA
duvelisib
CLL
follicular lymphoma
small lymphocytic lymphoma
#ASH17: Verastem’s AbbVie castoff is headed for the FDA — even after missing overall survival goal
Endpoints
Sun, 12/10/17 - 11:22 pm
ASH17
AbbVie
Verastem
FDA
duvelisib
chronic lymphocytic leukemia
Verastem moves closer to US filing for blood cancer drug
BioPharma Dive
Wed, 11/1/17 - 06:58 pm
Verastem
duvelisib
chronic lymphocytic leukemia
small lymphocytic lymphoma
Verastem bet on blood cancer drug pays off with trial success
BioPharma Dive
Wed, 09/6/17 - 08:31 pm
Verastem
clinical trials
duvelisib
On the ropes, Infinity gets a deal for duvelisib, with $0 up front as PI3k flounders
Endpoints
Wed, 11/2/16 - 09:51 am
duvelisib
Infinity Pharmaceuticals
Verastem
Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Yahoo
Thu, 03/3/16 - 10:44 am
Merck
Pfizer
Verastem
ovarian cancer
clinical trials
avelumab
VS-6063
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
10 Worst NASDAQ Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:51 pm
Orexigen
Immunomedics
Celldex Therapeutics
Arena Pharmaceuticals
Theravance
Karyopharm
Raptor Pharmaceutical
Verastem
Tetraphase
Xoma
Verastem concedes lead drug flopped in PhII mesothelioma study
Fierce Biotech
Mon, 09/28/15 - 08:21 am
Verastem
mesothelioma
Defactinib
clinical trials
After two deaths, Verastem defends safety of experimental cancer drug
Bizjournals.com
Wed, 08/26/15 - 08:43 pm
Verastem
VS-6063
non-small cell lung cancer
Large U.S. cancer trial to match genetic glitches to targeted drugs
Yahoo/Reuters
Mon, 06/1/15 - 07:49 pm
clinical trials
Pfizer
Xalkori
Boehringer Ingelheim
Gilotrif
Roche
Kadcyla
AZD9291
AstraZeneca
VS-6063
Verastem
personalized medicine

Pages